Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19

Mohamad Raad1, Mohammed Dabbagh1, Sarah Gorgis1

  • 1Division of Cardiology, Department of Medicine, Henry Ford Hospital, Detroit, Michigan.

Insights

Cardiac injury is common in COVID-19 patients. Higher peak high-sensitivity troponin-I (hs-cTnI) levels indicate greater cardiac injury and are linked to increased mortality risk in Coronavirus Disease 2019 (COVID-19) patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Biochemistry

Background:

  • Certain risk factors are linked to increased morbidity and mortality in Coronavirus Disease 2019 (COVID-19) patients.
  • The specific impact of cardiac injury and high-sensitivity troponin-I (hs-cTnI) concentrations on COVID-19 outcomes requires further elucidation.

Purpose of the Study:

  • To investigate the prevalence and impact of cardiac injury, defined by hs-cTnI concentrations, on outcomes in hospitalized Coronavirus Disease 2019 (COVID-19) patients.
  • To determine the association between varying hs-cTnI levels and patient outcomes, including mortality, length of stay, and need for intensive care.

Main Methods:

  • A large retrospective longitudinal cohort study was conducted on 1,020 consecutively admitted Coronavirus Disease 2019 (COVID-19) patients.
  • Cardiac injury was defined as hs-cTnI concentration exceeding the 99th percentile.
  • Patient characteristics, laboratory data, and outcomes were analyzed, with a focus on hs-cTnI concentrations and mortality as the primary outcome.

Main Results:

  • 38% of hospitalized Coronavirus Disease 2019 (COVID-19) patients presented with cardiac injury.
  • Patients with cardiac injury were older, had more cardiovascular disease, and higher inflammatory markers.
  • Higher peak hs-cTnI concentrations were significantly associated with increased mortality, even after multivariate regression analysis controlling for other factors.

Conclusions:

  • Cardiac injury is a frequent occurrence in Coronavirus Disease 2019 (COVID-19) admissions.
  • The extent of cardiac injury, indicated by peak hs-cTnI levels, is a significant predictor of adverse outcomes.
  • Peak hs-cTnI concentrations are crucial for assessing prognosis in COVID-19 patients.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
135
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
231
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
720
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
266
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
170
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
97